FEATURES OF STENTING IN PATIENTS WITH MALIGNANT STENOSIS
Article Sidebar
Main Article Content
Abstract
Dysphagia is a common problem. One in 17 people will develop some form of dysphagia during their lifetime. A 2011 UK study shows a prevalence of dysphagia of 11% in the general population [9]. The condition develops in 40–70% of patients with stroke, 60–80% of patients with neurodegenerative diseases, nearly 13% of adults aged 65 and older, and >51% of elderly patients in nursing homes [10,11]. It also affects 60–75% of patients receiving radiotherapy for head and neck cancer.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
References
Dengina NV Modern therapeutic possibilities for esophageal cancer (In Russian) // Practical Oncology. - 2012. Vol.13, No 4. - P. 47 - 56.
Cools-Lartigue J, Jones D, Spicer J, Zourikian T, Rousseau M, Eckert E, et al. Management of dysphagia in esophageal adenocarcinoma patients undergoing neoadjuvant chemotherapy: can invasive tube feeding be avoided? Ann Surg Oncol 2015; 22: 1858–65. doi: https://doi.org/10.1245/s 10434-014-4270-9.
Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D. European Society for Medical Oncology (ESMO) European Society of Surgical Oncology (ESSO) European Society of Radiotherapy and Oncology (ESTRO) Gastric cancer: ESMO-ESSO- ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24 (Suppl 6): vi57–vi63. doi: https://doi.org/10.1093/annonc/mdt344.
Park JH, Song HY, Kim JH, Jung HY, Kim JH, Kim SB, Lee H, et al. Polytetrafluoroethylene-covered retrievable expandable nitinol stents for malignant esophageal obstructions: factors influencing the outcome of 270 patients. AJR Am J Roentgenol 2012; 199: 1380–6. doi: https://doi.org/10. 2214/AJR. 10.6306.
Na HK, Song HY, Kim JH, Park JH, Kang MK, Lee J, et al. [8] How to design the optimal self-expandable oesophageal metallic stents: 22 years of experience in 645 patients / J Surg Oncol 2012; 105:60–5. doi:https://doi.org/10.1002/js o.22059.
Doosti-Irani A, Mansournia MA, Rahimi-Foroushani A, Haddad P, Holakouie-Naieni K. Complications of stent placement in patients with esophageal cancer: A systematic with malignant strictures. // Eur Radiol 2013; 23:786–96. doi: https://doi.org/10.1007/s00330-012-2661-5.
Park JH, Song HY, Shin JH, Cho YC, Kim JH, Kim SH, et al. Migration of retrievable expandable metallic stents inserted for malignant esophageal strictures: incidence, management, and prognostic factors in 332 patients. AJR Am J Roentgenol 2015; 204:1109–14. doi: https://doi.org/10.2214/AJR.14.13 172.
Battersby NJ, Bonney GK, Subar D, Talbot L, Decadt B, Lynch N. Outcomes following oesophageal stent insertion for palliation of malignant strictures: A large single center series. // Copyright © 2022 The Author(s). Published by Scientific & Academic Publishing review and network meta-analysis. PLoS One 2017; 12: e0184784. doi:https://doi.org/10.1371/journal.pone.0184784.
Wagh MS, Forsmark CE, Chauhan S, Draganov PV. Efficacy and safety of a fully covered esophageal stent: a prospective study. Gastrointest Endosc 2012; 75:678–82. doi: https://doi.org/10.1016j.gie. 2011. 10.006.
Stahl M, Mariette C, Haustermans K, Cervantes A, Arnold D. ESMO Guidelines Working Group Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2017; 24 (Suppl 6): vi51–vi56. doi: https://doi. org/10.1093/annonc/mdt342.